PICCLINER's Profile
Displaying 51-100 of 648 result(s).
Go to page:
Recent Articles
- Movano Inc. Stock Surges Significantly on Listing Extension News
- Strathcona Resources' Strategic Move to Enhance Shareholding
- Friends of Science Society Raises Concerns Over Net Zero Demands
- Secure Your Rights: Advocating for Replimune Group Investors
- RxSight Securities Class Action: What Investors Need to Know
- Pollo AI Unveils Game-Changing AI Tool for Creators
- Global Leaders Gather for China's Significant 80th V-Day Event
- Gmail's Spam Filtering Under Fire: Is Political Bias at Play?
- Secure Your Rights: Luminar Technologies Investors Alert
- Investors of Sable Offshore Corp. Urged to Act Promptly
- Investors of Lockheed Martin Corporation Must Act Quickly for Class Action
- PharmaResearch Partners with VIVACY to Boost 'Rejuran' in Europe
- Bitcoin Holds Steady While Altcoins Face Disappointing Trends
- PharmaResearch Forms New Alliance for Rejuran Across Europe
- PharmaResearch Partners with VIVACY for Expanded European Reach
- Solar Alliance Energy Inc. Prepares For Market Re-entry After Trading Pause
- SF Intra-city Reports Surge in Revenue and Growth for 2025
- TMC Financing Welcomes Omar Salah as New President and CEO
- Concerns Rise Over Salmonella Outbreak from Eggs in the U.S.
- Top Five Stocks Captivating Investors This Trading Day
- SF Intra-city's Exceptional Performance Fuels Dynamic Growth
- Apex Institute Disrupts Job Training with AI-Driven Bootcamp
- TransUnion Faces Major Data Breach Investigation Amidst Chaos
- Experience Edo Culture Through Unique Tokyo Tours and Cruises
- Soma Gold Corp Posts Strong Financial Results for Q2 2025
- E&R Engineering to Showcase Cutting-Edge Tech at SEMICON 2025
- Exciting Launch of the Mini Labubu Pendant on AliExpress
- Exciting Developments at Freedom Plaza with Local Support
- Netflix Stock Surges as Power Inflow Signals Uptrend
- Exploring E&R's Cutting-Edge Technologies at SEMICON Taiwan
- Mesoblast's Milestones: FDA Approval and Strategic Growth
- Highlights of Mesoblast's Record Year: FDA Approval and Growth
- Replimune Group Inc. Class Action Update for Shareholders
- Faruqi & Faruqi Investigates Replimune Group for Shareholders
- Frontier Lithium Releases Financial Milestones and Updates
- Expansion in Water Sector: Scruggs and NTS Join Forces
- Gamehaus Holdings Inc. Launches Strategic Share Buyback Plan
- Bogotá's Strategic Mission to Enhance Investment with Japan
- Exciting Developments at Picard Medical with $17 Million IPO
- Eagle Pharmaceuticals Welcomes Abhinav Jain to Its Board
- Stetson University Celebrated for Distinction in Education
- Sable Offshore Investors Rally: Legal Actions Begin
- Transform Your Investment Strategy with US Foods Holdings Today
- Investors Alert: LifeMD Inc Faces Legal Investigation Risks
- Everest Medicines Reports Strong Interim Growth in 2025
- Simply Solventless Sees Exceptional Growth with $13 Million in Revenue
- Everest Medicines Reports Strong Financial Growth for H1 2025
- Exploring Adobe's Stock Growth Track Record Over Two Decades
- Faruqi & Faruqi Investigates Flywire Corporation's Claims
- Investigation into Petco's Shareholder Claims and Stock Trends
